Share chart Heron Therapeutics
Extended chart
Simple chart
About Heron Therapeutics
Heron Therapeutics, Inc., биотехнологическая компания, занимается разработкой методов лечения для удовлетворения неудовлетворенных медицинских потребностей. Продукты-кандидаты компании используют ее запатентованный биохрономер, технологию доставки лекарств, которая обеспечивает терапевтические уровни ряда фармакологических агентов короткого действия в течение периода от нескольких дней до недель за одно введение. more details| IPO date | 1987-08-26 |
|---|---|
| ISIN | US4277461020 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.herontx.com |
| Цена ао | 1.5 |
| Change price per day: | +3.98% (1.76) |
|---|---|
| Change price per week: | +12.27% (1.63) |
| Change price per month: | +15.82% (1.58) |
| Change price per 3 month: | -1.08% (1.85) |
| Change price per half year: | -34.88% (2.81) |
| Change price per year: | -26.51% (2.49) |
| Change price per 3 year: | -65.54% (5.31) |
| Change price per 5 year: | -90.77% (19.82) |
| Change price per 10 year: | -84.16% (11.55) |
| Change price per year to date: | +15.82% (1.58) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
|---|---|---|---|---|---|---|---|---|---|
| 03.05.2022 | 04.05.2022 | MANHARD KIMBERLY EVP, Drug Development |
Sale | 4.76 | 7 159 | 1504 | 0 | 0 | link |
| Institutions | Volume | Share, % |
|---|---|---|
| Rubric Capital Management LP | 26713503 | 17.77 |
| Vanguard Group Inc | 8338912 | 5.55 |
| Blackrock Inc. | 7162352 | 4.76 |
| Velan Capital Investment Management LP | 6986744 | 4.65 |
| Franklin Resources, Inc. | 6404795 | 4.26 |
| Clearline Capital, LP | 6068554 | 4.04 |
| Orbimed Advisors LLC. | 5928591 | 3.94 |
| Tejara Capital Ltd | 5275236 | 3.51 |
| Palisade Capital Management, L.P. | 3646103 | 2.43 |
| Adage Capital Partners GP L.L.C. | 2910011 | 1.94 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Jacob Forward ETF | 4.45367 | 43.03 | 0.15284 |
| Vanguard U.S. Momentum Factor ETF | 0.11 | 30.05 | 1.05834 |
| iShares Micro-Cap ETF | 0.06192 | 17.09 | 1.54048 |
| Direxion Daily S&P Biotech Bull 3x Shares | 0.04232 | 4067.92 | 0.25924 |
| Principal U.S. Small-Cap ETF | 0.02687 | 16.7 | 1.20466 |
| Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.02537 | 31.36 | 1.41955 |
| Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
Schwab U.S. Small-Cap ETF
|
0.00738 | 17.47 | 1.51433 |
ProShares UltraPro Russell2000
|
0.00523 | 89.82 | 1.47873 |
iShares Russell 2000 Growth ETF
|
0.00192 | 38.04 | 0.6026 |
| ProShares Hedge Replication ETF | 0.0014 | 5.92 | 1.47892 |
Schwab U.S. Broad Market ETF
|
0.00048 | 24.86 | 1.43354 |
| iShares Russell 3000 ETF | 0.0004 | 24.83 | 1.43482 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| Vanguard Russell 2000 Growth ETF | 0 | 23.05 | 0.60264 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Craig Alexander Collard | CEO & Director | N/A | 1966 (59 years) |
| Ms. Ira Duarte | Executive VP & CFO | N/A | 1969 (56 years) |
| Dr. William P. Forbes Pharm. D., Pharm.D. | Executive VP & Chief Development Officer | 1962 (63 years) | |
| Mr. Ryan Craig | Vice President of Marketing | ||
| Mr. Sean T. Ristine | Senior Vice President of Human Resources | 1970 (55 years) | |
| Mr. Robert Sullivan | Senior Vice President of Oncology Care Franchise & Commercial Operations | 1978 (47 years) | |
| Mr. Brett Fleshman | Chief Business Officer | ||
| Jeff Cohn | Executive Director, Assistant General Counsel & Assistant Secretary |
Address: United States, San Diego, CA , 4242 Campus Point Court - open in Google maps, open in Yandex maps
Website: http://www.herontx.com
Website: http://www.herontx.com
